Variation in Restarting Antithrombotic Drugs at Hospital Discharge After Intracerebral Hemorrhage | Zendy

M. Pasquini | Zendy; Andreas Charidimou | Zendy; Charlotte J.J. van Asch | Zendy; Merih I. Baharoglu | Zendy; Neshika Samarasekera | Zendy; David J. Werring | Zendy; Catharina J.M. Klijn | Zendy; Yvo B.W.E.M. Roos | Zendy; Rustam AlShahi Salman | Zendy; Charlotte Cordonnier | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Variation in Restarting Antithrombotic Drugs at Hospital Discharge After Intracerebral Hemorrhage

Author(s) -

M. Pasquini,

Andreas Charidimou,

Charlotte J.J. van Asch,

Merih I. Baharoglu,

Neshika Samarasekera,

David J. Werring,

Catharina J.M. Klijn,

Yvo B.W.E.M. Roos,

Rustam AlShahi Salman,

Charlotte Cordonnier

Publication year - 2014

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.114.006202

Subject(s) - antithrombotic , medicine , intracerebral hemorrhage , atrial fibrillation , cohort , logistic regression , stroke (engine) , fibrinolytic agent , pharmacoepidemiology , pharmacology , medical prescription , subarachnoid hemorrhage , mechanical engineering , engineering

Whether intracerebral hemorrhage (ICH) survivors should restart antithrombotic drugs is unknown. We analyzed the frequency of restarting antithrombotic drugs in ICH survivors who had taken prophylactic antithrombotic drugs in atrial fibrillation or after thromboembolic disease in 5 cohorts and explored factors associated with doing so.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research